Paul W. Hawran, Executive VP and CFO at NEUROCRINE BIOSCIENCES INC (NBIX), sold 115,481 shares at $20.10 ($2.3M) on 2006-05-17, disclosed to the SEC on 2006-05-18.
Open-market sale of $2.3M NBIX by Executive VP and CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.66 | 5,000 | $98K | 4.3% |
| 2 | $19.68 | 31,144 | $613K | 26.8% |
| 3 | $19.70 | 22,500 | $443K | 19.4% |
| 4 | $19.80 | 20,000 | $396K | 17.3% |
| 5 | $19.85 | 3,500 | $69K | 3.0% |
| 6 | $19.85 | 7,500 |
| $149K |
| 6.5% |
| 7 | $19.86 | 2,949 | $59K | 2.6% |
| 8 | $19.87 | 500 | $10K | 0.4% |
| 9 | $19.88 | 200 | $4K | 0.2% |
| 10 | $19.89 | 78 | $2K | 0.1% |
| 11 | $19.90 | 3,273 | $65K | 2.8% |
| 12 | $19.93 | 2,598 | $52K | 2.3% |
| 13 | $19.97 | 10,000 | $200K | 8.7% |
| 14 | $20.10 | 2,461 | $49K | 2.2% |
| 15 | $20.11 | 200 | $4K | 0.2% |
| 16 | $20.12 | 830 | $17K | 0.7% |
| 17 | $20.14 | 1,000 | $20K | 0.9% |
| 18 | $20.14 | 48 | $967 | 0.0% |
| 19 | $20.50 | 1,400 | $29K | 1.3% |
| 20 | $20.60 | 300 | $6K | 0.3% |
| Total | $19.79 avg | 115,481 | $2.3M | 100% |
| Filing → |
| CYTX | BUY | 2010-05-19 | $24K | — | Filing → |
| CYTX | BUY | 2009-11-25 | $25K | — | Filing → |
| CYTX | BUY | 2009-11-24 | $24K | — | Filing → |